A new study from the California HIV/AIDS Policy Research Centers, in collaboration with the Center on Reproductive Health, Law, and Policy, Birth Control Pharmacist, and the California Society of Health-System Pharmacists, finds that more than 90% of California pharmacists surveyed believed that access to HIV prevention medications in pharmacies is important. Researchers examined attitudes, knowledge, and preferences around the provision of HIV prevention and other sexual and reproductive health services by pharmacists. The researchers also assessed the implementation of state policies that enable pharmacists to prescribe PrEP and PEP. Read and/or download a 2-page policy brief about the HIV prevention results of this study here.
Send this to a friend